Xia, Liang-Ping <br/><br/>
Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 cases.  [electronic resource] 

 -  Medical oncology (Northwood, London, England)  Dec 2011 
 - S570-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1559-131X 
<br/><br/><label>Standard No.: </label>10.1007/s12032-010-9709-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Asian People<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cetuximab<br/>Exanthema--chemically induced<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Time Factors<br/>Treatment Outcome